Jeil Health Science, Inc. – FDA Inspection, Mar 17, 2017

Record Details

This FDA Inspection record concerns Jeil Health Science, Inc., with an inspection on March 17, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Jeil Health Science, Inc.
Inspection Date: March 17, 2017
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Tajah L. Blackburn (FDA Associated Person)

View Company Profile

ID · e690296f-209c-4872-9e5e-37bbe5fbcc98

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1007399
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jeil Health Science, Inc.

FDA Inspection

Jeil Health Science, Inc.March 17, 2017